Pilot Study of a Raltegravir Based NRTI Sparing Regimen

NCT00814879 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acquired Immune Deficiency Syndrome
AIDS
Human Immunodeficiency Virus
HIV Infections

Interventions

DRUG: Raltegravir
DRUG: Atazanavir
OTHER: Standard treatment regimen

Sponsor

Yale University

Collaborators

[object Object]
[object Object]